Genmab

This study tested a new drug called PRO1160 in people with advanced kidney cancer, nasopharyngeal cancer, or non-Hodgkin lymphoma that had spread or come back after other treatments. The goal was to find a safe dose and see if the drug shrinks tumors. The trial was stopped early,…

This study tested a new drug, GEN1286, in 23 adults with advanced solid tumors that had spread or could not be removed. The goal was to check safety, side effects, and whether the drug could shrink tumors. The trial was stopped early, so results are limited.

This early-stage trial tested a new antibody drug called GEN1057 in 23 people with advanced solid tumors that had stopped responding to standard treatments. The main goals were to check safety and find the right dose. The study was terminated early, so results are limited.

This study tested a new drug called PRO1107 in 33 people with advanced solid tumors, including ovarian, endometrial, and lung cancers. The goal was to check safety and see if the drug could shrink tumors. The trial was stopped early, so results are limited.

This study tested a new antibody drug called GEN3014 in people with multiple myeloma or other blood cancers that had come back or stopped responding to treatment. The main goal was to check the drug's safety and find the best dose. The trial was stopped early, but the results hel…

This trial tested a new drug called GEN1047 in 179 people with advanced solid tumors (breast, endometrial, ovarian, or lung cancer) that had stopped responding to standard treatments. The main goals were to check safety, side effects, and how the body processes the drug. The stud…

This early-stage trial tested a new drug called GEN3017 in 9 people with CD30-positive Hodgkin or Non-Hodgkin lymphoma that had returned or stopped responding to other treatments. The goal was to check the drug's safety and how well the body tolerates it. The study was terminated…

This trial tested a new antibody drug, GEN1055, in adults with advanced solid tumors. It was given alone or with pembrolizumab (with or without chemotherapy) to see if it is safe and works against cancer. The study was stopped early, but the goal was to find the best dose and mea…

This trial tested a new drug, GEN1078, in 3 people with advanced solid tumors that had stopped responding to standard treatments. The main goals were to check for side effects and see how the body processes the drug. The study was stopped early, so results are limited.

This early-stage trial tested a new drug (GEN1042) combined with radiation, with or without another immunotherapy (pembrolizumab), in 13 adults with metastatic solid tumors that had no standard treatment options. The goal was to see if the combination was safe and could shrink tu…